Calendar Recce Pharmaceuticals Ltd

Equities

Market Closed - Australian S.E. Other stock markets 02:10:44 2024-04-26 am EDT			5-day change	1st Jan Change
0.67 ^AUD	-2.19%		+26.42%	+25.23%

Apr. 17	Recce Pharmaceuticals Ltd. Completes 5,000 RECCE 327 Doses Week Under Good Manufacturing Practice	CI
Apr. 16	Recce Pharmaceuticals Advances Production of Anti-Infective Medication	MT

53b67a47fde.av_H2m29awN_uScmzF36_t_K187RZ3iwHpctIdsbcco.Gb6Ugh7aAVk6wHMTtAScjPLytaW2Mj3Gdv55YO5fQ5MAiYaVK8oqWUvIcg~a49e11f664d35e2208ec60eddb1d7b1b

2024-08-29	Q4 2024 Earnings Release (Projected)
2025-02-25	Q2 2025 Earnings Release (Projected)
2025-08-28	Q4 2025 Earnings Release (Projected)
2026-03-03	Q2 2026 Earnings Release (Projected)

2024-03-28 07:00 pm	American Society for Clinical Pharmacology & Therapeutics Meeting
2024-02-28 04:21 am	Q2 2024 Earnings Release
2024-01-29 08:19 pm	December 2023 Sales and Revenue Release - Activities Report
2023-11-07 05:00 pm	Annual General Meeting
2023-10-19 07:28 pm	September 2023 Sales and Revenue Release - Activities Report
2023-08-31 01:34 am	Q4 2023 Earnings Release
2023-08-16 10:00 am	Military Health System Research Symposium - Abstract No : MHSRS-23-10081
2023-07-31 04:15 am	June 2023 Sales and Revenue Release - Activities Report
2023-04-28 12:04 am	March 2023 Sales and Revenue Release - Activities Report
2023-03-23	Wholesale Investor Emergence Conference
2023-02-27 02:04 am	Q2 2023 Earnings Release
2023-02-23	Spark Plus Biotech Day
2023-02-14	Wholesale Investor Emergence Conference
2023-01-29	December 2022 Sales and Revenue Release - Activities Report
2022-11-13 10:00 pm	Annual General Meeting
2022-11-02 11:45 pm	Spark Plus Biotech & Medical Device Webinar
2022-10-27 08:48 pm	September 2022 Sales and Revenue Release - Activities Report
2022-08-30	FY 2022 Earnings Release
2022-07-31	June 2022 Sales and Revenue Release - Activities Report
2022-07-27 09:00 pm	Spark Australian Equities Day

Fiscal Period	Juni	2022	2023	2024
Net sales Million AUD	Released Forecast Spread	0,00	4,31 6,22 -30.68%	5,24
EBITDA Million AUD	Released Forecast Spread	0,00	-12,8 -12,3 -3.88%	-14,8
EBIT Million AUD	Released Forecast Spread	0,00	-12,7 -12,2 -4.23%	-15,0
Earnings before Tax (EBT) Million AUD	Released Forecast Spread	0,00	-13,1 -12,4 -5.1%	-15,3
Net income Million AUD	Released Forecast Spread	-11,0	-13,1 -12,4 -5.1%	-15,3
EPS AUD	Released Forecast Spread	-0,06	-0,08 -0,07 -7.43%	-0,08
Announcement Date		31/08/22	31/08/23	-

2024-04-28	SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28	SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
2024-04-28	BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28	JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28	AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-28	PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
2024-04-28	SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28	ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-28	ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28	WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release

Today	LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
Today	NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today	LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
Today	HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today	ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today	GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today	GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today	NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today	ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today	ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release